Skip to main content

FDx Advisors, Inc.

Position in NVS — Novartis AG

CIK 1566601 BERWYN, PA

Position in NVS

as of Jun 30, 2026 · filed Aug 4, 2026
Position Value
$840,332
+$205,503 QoQ
Shares Held
5,362
+29.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.09%
of 13F equity value
Holder Rank
#682
of 1,603 holders
Holding Since
Mar 2020
19 quarters on record

Common Shares in NVS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

FDx Advisors, Inc. holds $3,475,495 across 7 Drug Manufacturers - General names. NVS ranks #1 (24.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 NVS
Novartis AG
This page
5,362 $840,332

All Filings in NVS

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $840,332 5,362
2026-03-31 $634,829 4,156
2024-03-31 $454,050 4,694
2023-12-31 $1,652,777 16,369
2023-09-30 $1,601,035 15,718
2023-06-30 $2,993,394 29,664
2023-03-31 $5,316,404 57,787
2022-12-31 $5,242,436 57,787
2022-09-30 $4,463,535 58,723
2022-06-30 $5,460,722 64,601
2022-03-31 $5,512,191 62,817
2021-12-31 $5,158,105 58,970
2021-09-30 $3,876,699 47,404
2021-06-30 $4,007,534 43,923
2021-03-31 $3,623,839 42,394
2020-12-31 $4,459,456 47,225
2020-09-30 $3,705,887 42,616
2020-06-30 $3,659,371 41,898
2020-03-31 $3,215,797 39,003